Management of dyslipidaemia in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey in 27 countries

G De Backer, P Jankowski, K Kotseva, E Mirrakhimov… - Atherosclerosis, 2019 - Elsevier
Background and aims One of the objectives of the ESC-EORP EUROASPIRE V survey is to
determine how well European guidelines on the management of dyslipidaemias are …
被引用次数：309 相关文章

Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries

G De Backer, P Jankowski, M Dilić, N Lalić… - …, 2019 - imagine.imgge.bg.ac.rs
Background and aims: One of the objectives of the ESC-EORP EUROASPIRE V survey is to
determine how well European guidelines on the management of dyslipidaemias are …

Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries

G de Backer, P Jankowski, K Kotseva, E Mirrakhimov… - Atherosclerosis, 2019 - repub.eur.nl
Background and aims: One of the objectives of the ESC-EORP EUROASPIRE V survey is to
determine how well European guidelines on the management of dyslipidaemias are …

[引用][C] Management of dyslipidaemia in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey in 27 countries

G De Backer, P Jankowski, K Kotseva, E Mirrakhimov… - Atherosclerosis, 2019 - ruj.uj.edu.pl
Management of dyslipidaemia in patients with coronary heart disease : results from the ESC-EORP
EUROASPIRE V survey in 27 countries Przejdź do treści Pomoc A A A Zmień kontrast Zaloguj …

Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries

G De Backer, P Jankowski, K Kotseva… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Background and aims One of the objectives of the ESC-EORP EUROASPIRE V survey is to
determine how well European guidelines on the management of dyslipidaemias are …

Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries

G De Backer, P Jankowski, K Kotseva… - … : Elsevier Ireland LTD …, 2019 - lsmu.lt
Methods: Standardized methods were used by trained technicians to collect information on
7824 patients from 130 centers in 27 countries, from the medical records and at a visit at …

Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries.

G De Backer, P Jankowski… - Atherosclerosis …, 2019 - unirepository.svkri.uniri.hr
BACKGROUND AND AIMS: One of the objectives of the ESC-EORP EUROASPIRE V survey
is to determine how well European guidelines on the management of dyslipidaemias are …

Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries

G De Backer, P Jankowski, K Kotseva… - …, 2019 - atherosclerosis-journal.com
Background and aims One of the objectives of the ESC-EORP EUROASPIRE V survey is to
determine how well European guidelines on the management of dyslipidaemias are …

Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries

G De Backer, D De Bacquer, P Jankowski, K Kotseva… - Atherosclerosis, 2019 - elibrary.ru
Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP
EUROASPIRE V survey in 27 countries КОРЗИНА ПОИСК НАВИГАТОР СЕССИЯ …

Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries.

G De Backer, P Jankowski, K Kotseva… - …, 2019 - europepmc.org
Methods Standardized methods were used by trained technicians to collect information on
7824 patients from 130 centers in 27 countries, from the medical records and at a visit at …